- Title
- Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa
- Authors/Creators
- E. Phillips (Author/Creator) - School of Pathology and Laboratory MedicineJ.A. Bartlett (Author/Creator) - Duke UniversityI. Sanne (Author/Creator) - University of the WitwatersrandM.M. Lederman (Author/Creator) - Environmental Health SciencesJ. Hinkle (Author/Creator) - EarlyPhase Sciences, Inc.F. Rousseau (Author/Creator) - GenzymeD. Dunn (Author/Creator) - Murdoch UniversityR. Pavlos (Author/Creator) - Murdoch UniversityI. James (Author/Creator) - Murdoch UniversityS.A. Mallal (Author/Creator) - Murdoch UniversityD.W. Haas (Author/Creator) - Vanderbilt University
- Publication Details
- JAIDS Journal of Acquired Immune Deficiency Syndromes, Vol.62(2), pp.e55-e57
- Publisher
- Lippincott Williams & Wilkins
- Identifiers
- 991005541681807891
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
- Note
- Letter
Journal article
Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa
JAIDS Journal of Acquired Immune Deficiency Syndromes, Vol.62(2), pp.e55-e57
2013
Details
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
27 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.66 HIV
- 1.66.1372 HIV Comorbidities
- Web Of Science research areas
- Immunology
- Infectious Diseases
- ESI research areas
- Immunology